503 High SVR Rates in Patients with Genotype 4 Chronic Hepatitis C Infection and Compensated Cirrhosis With Ombitasvir/Paritaprevir/Ritonavir Co-Administered With Ribavirin (AGATE-I)

High SVR Rates in Patients with Genotype 4 Chronic Hepatitis C Infection and Compensated Cirrhosis with Ombitasvir/Paritaprevir/Ritonavir Co-Administered with Ribavirin (AGATE-I)

10.1016/s0168-8278(16)01618-4 ◽

2016 ◽

Vol 64 (2) ◽

pp. S827

Author(s):

T. Asselah ◽

C. Hezode ◽

R.B. Qaqish ◽

M. ElKhashab ◽

T. Hassanein ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Genotype 4 ◽

Toll-like receptors 7 and 8 mRNA in monocytes of Egyptian children with chronic hepatitis C infection genotype 4 as predictor to “response” interferon and ribavirin treatment

Egyptian Pediatric Association Gazette ◽

10.1016/j.epag.2016.01.001 ◽

2016 ◽

Vol 64 (1) ◽

pp. 6-12 ◽

Cited By ~ 1

Author(s):

Mohammed A. Khedr ◽

Hatem A. Kanswa ◽

Magdy A. Saber ◽

Tawfik M. Abdel-Motilb

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Toll Like Receptors ◽

Hepatitis C Infection ◽

Genotype 4 ◽

Egyptian Children

Results of Sofosbuvir (SOF) Based Combination Therapy for Chronic Hepatitis C Infection Including Compensated Cirrhosis: A Real Life Clinical Practice Experience

Journal of Clinical and Experimental Hepatology ◽

10.1016/j.jceh.2017.05.047 ◽

2017 ◽

Vol 7 ◽

pp. S21

Author(s):

Kamlesh Kumar ◽

Gaurav Pandey ◽

Hemant K. Nayak ◽

Samir Mohindra ◽

Vivek A. Saraswat

Keyword(s):

Chronic Hepatitis ◽

Clinical Practice ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Real Life ◽

Hepatitis C Infection ◽

Compensated Cirrhosis ◽

Practice Experience

Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(21)00031-5 ◽

2021 ◽

Cited By ~ 1

Author(s):

Isabelle Andrieux-Meyer ◽

Soek-Siam Tan ◽

Sombat Thanprasertsuk ◽

Nicolas Salvadori ◽

Caroline Menétrey ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interim Analysis ◽

Phase 2 ◽

Efficacy And Safety ◽

Hepatitis C Infection ◽

Open Label ◽

Two Stage ◽

Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04370.x ◽

2010 ◽

Vol 32 (3) ◽

pp. 344-355 ◽

Cited By ~ 121

Author(s):

W. Alazawi ◽

M. Cunningham ◽

J. Dearden ◽

G. R. Foster

Keyword(s):

Systematic Review ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

P1345 : A randomized, open-label study to evaluate efficacy and safety of ombitasvir/paritaprevir/ritonavir co-administered with ribavirin in adults with genotype 4 chronic hepatitis C infection and cirrhosis

10.1016/s0168-8278(15)31524-5 ◽

2015 ◽

Vol 62 ◽

pp. S861 ◽

Cited By ~ 4

Author(s):

T. Asselah ◽

T. Hassanein ◽

R.B. Qaqish ◽

J.J. Feld ◽

C. Hezode ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Efficacy And Safety ◽

Hepatitis C Infection ◽

Open Label ◽

Genotype 4 ◽

Open Label Study ◽

Label Study

1038 NATURAL HISTORY OF COMPENSATED CIRRHOSIS DUE TO CHRONIC HEPATITIS C INFECTION: A SYSTEMATIC REVIEW

10.1016/s0168-8278(10)61039-2 ◽

2010 ◽

Vol 52 ◽

pp. S402

Author(s):

W. Alazawi ◽

M. Cunningham ◽

J. Dearden ◽

G.R. Foster

Keyword(s):

Systematic Review ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Natural History ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Compensated Cirrhosis ◽

History Of

Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?

Hepatology ◽

10.1002/hep.510230439 ◽

1996 ◽

Vol 23 (4) ◽

pp. 930-933 ◽

Cited By ~ 10

Author(s):

S E Harper ◽

J L Dienstag

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alfa ◽

Hepatitis C Infection ◽

PWE-042 Natural history of compensated cirrhosis due to chronic hepatitis C infection: a systematic review

Gut ◽

10.1136/gut.2009.208967l ◽

2010 ◽

Vol 59 (Suppl 1) ◽

pp. A101.2-A101

Author(s):

W Alazawi ◽

M Cunningham ◽

J Dearden ◽

G R Foster

Keyword(s):

Systematic Review ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Natural History ◽

Chronic Hepatitis C ◽

Hepatitis C Infection ◽

Compensated Cirrhosis ◽

History Of

Kinetics of cellular immune responses during the early phase of IFN + ribavirin therapy of chronic hepatitis C infection

10.1016/s0168-8278(01)80564-x ◽

2001 ◽

Vol 34 (0) ◽

pp. 155 ◽

Cited By ~ 1

Author(s):

H Liermann

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Immune Responses ◽

Chronic Hepatitis C ◽

Early Phase ◽

Hepatitis C Infection ◽

Cellular Immune Responses ◽

Cellular Immune ◽

Kinetics Of